Conversely, the co-activation of Dectin-1 and the TNF receptor superfamily member CD40 with agonists alters the phenotype of pro-tumoral Tumor-Associated Macrophages (TAMs) within the tumor microenvironment, enhancing anti-tumor immunity and impeding tumor progression [22]. This evidence concerns the gene CD40 and neoplasm.